Clinical Trial Update: Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ex vivo-activated autologous lymph node lymphocytes in patients with chronic lymphocytic leukemia; study status completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ex vivo-activated autologous lymph node lymphocytes

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anemia, Cancer Fatigue | Phase 2 | Status: COMPLETED | Results posted: 2019-10-29